DVS Sciences and Cytobank announce partnership to analyze and manage high-parameter mass cytometry data

SUNNYVALE, Calif. & MOUNTAIN VIEW, Calif. - Sunday, June 24th 2012 [ME NewsWire]

(BUSINESS WIRE)-- DVS Sciences, Inc., a privately held innovator and manufacturer of novel CyTOF® multi-parameter single-cell analyzers and reagents for biological research, today announced a business agreement with Cytobank, Inc., a privately held developer of cloud based scientific, informatics and software solutions for the flow cytometry market.

The CyTOF mass cytometry platform developed by DVS Sciences enables revolutionary understanding of cellular dynamics of disease states, identification of stem cells and unprecedented insight into other biological systems using metal conjugated antibodies bound to cells and analyzed by time of flight mass spectrometry. The technology uniquely has the capability to simultaneously measure up to 100 cell biomarkers in single cells at up to 1000 cells per second. The software platform created by Cytobank enables researchers to analyze and manage the data acquired on CyTOF instruments using a novel cloud computing platform integrated with proprietary algorithms for data analysis. Together, DVS Sciences and Cytobank will co-develop and release an integrated solution, “DVS Cytobank™”, that automatically analyzes and manages the large data sets resulting from CyTOF instruments, while concurrently providing information on reagent panels and protocols. The new venture enables and simplifies the analysis of the massively multi-parameter mass cytometry data. DVS Cytobank is a proprietary implementation developed specifically for mass cytometry data, capitalizing on the Cytobank platform and provided by DVS Sciences directly to researchers using the CyTOF platform.

“The marriage of uniquely informative data acquired by our CyTOF instruments and reagents with the powerful capabilities of the Cytobank cloud based platform will be enabling for our researchers around the world as they analyze, manage, and share large amounts of multi-parameter data,” says Joseph Victor, President & CEO of DVS Sciences. Nikesh Kotecha, Ph.D , CEO & Co-founder of Cytobank adds, “we are excited to be partnering with DVS Sciences to create a software solution that enables the next generation of high dimensional cytometry and single cell systems biology brought about by the CyTOF instrument.”

An early access version of DVS Cytobank will be released to the customers of DVS Sciences in August with a formal release available by November, 2012. For more information about the DVS Cytobank product, visit the site page at dvs.cytobank.org. For more information about DVS Sciences and the CyTOF mass cytometry platform, please visit www.DVSsciences.com. For more information about Cytobank, visit www.cytobankinc.com.

About DVS Sciences, Inc.

DVS Sciences, Inc. manufactures and globally distributes novel bioanalytical solutions for use in biomarker discovery, biological research and potential future use in clinical applications. The patented multi-parameter technology comprises a high-throughput mass cytometer for quantitative individual cell analysis, CyTOF, and a suite of reagents, which include stable-isotope-tagged antibodies. The CyTOF platform overcomes the limitations of conventional flow cytometry, simplifies sample preparation and can simultaneously identify up to 100 biomarkers with high resolution and wide dynamic range. CyTOF systems are installed in leading laboratories across the U.S., Canada, Europe and Asia. DVS Sciences has its global headquarters and reagent kit manufacturing in Sunnyvale, California with a R&D and instrument manufacturing facility near Toronto, Canada and a sales/support office in the UK.

About Cytobank, Inc.

Cytobank, Inc. develops, hosts, and supports cloud-computing software applications tailored for bioscience researchers, collaborators, and core labs using flow cytometry. Based in Mountain View, CA, in the heart of Silicon Valley, Cytobank, Inc. was founded and is managed by scientist-entrepreneurs from Stanford University with a unique blend of expertise in flow cytometry, cell signaling networks, drug discovery, informatics and software development. Cytobank software is used around the world by thousands of academic and industrial researchers to manage, share, and analyze their cytometry data.

Contacts

DVS Sciences, Inc.

Tad George, +1 408-900-7214

tad.george@DVSsciences.com



Cytobank, Inc.

Nikesh Kotecha, +1 650-918-7966 x100

nikesh.kotecha@cytobank.org